Nanotechnological Strategies as Smart ways for Diagnosis and Treatment of the Atherosclerosis

Author(s): Virna M. Martín Giménez, Alejandra B. Camargo, Diego Kassuha, Walter Manucha*

Journal Name: Current Pharmaceutical Design

Volume 24 , Issue 39 , 2018

Become EABM
Become Reviewer
Call for Editor


Atherosclerosis provokes a continuous worsening of affected vessels causing a blood flow diminution with several complications and with clinical manifestations that generally appear in advanced phases of the illness. Hence, the conventional therapies are not enough because the atherosclerotic injuries are often irrevocable. For this reason, emerges the necessity to implement smart ways of drug supply and develop new therapeutic targets that decrease the advance atherosclerotic lesion. It results due to particular interest to use new tools for prevention, diagnosis, and treatment of this cardiovascular disease, thus concentrating our attention to accomplish better management on the immune system. Finally, this mini-review highlights the most recent knowledge about nanotechnology as a robust, novel and promissory therapeutic option applied to atherosclerotic pathology, nevertheless, we also alert for possible issues associated with their use.

Keywords: atherosclerosis, treatment, diagnosis, nanotechnology, immune system, blood flow.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 14 March, 2019
Page: [4681 - 4684]
Pages: 4
DOI: 10.2174/1381612825666190110154609
Price: $65

Article Metrics

PDF: 19
PRC: 1